Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Bristol-Myers Squibb (NY: BMY)
52.79 USD  +0.54 (+1.03%)
Official Closing Price  /  Updated: 7:58 PM EDT, Mar 27, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 14,498,300
Open 51.11
Bid (Size) 50.50 (1)
Ask (Size) 53.85 (1)
Prev. Close 52.25
Today's Range 50.87 - 53.78
52wk Range 42.48 - 68.34
Shares Outstanding 1,634,538,458
Dividend Yield 3.03%
Performance
YTD
-16.66%
-16.66%
1 Month
-10.62%
-10.62%
3 Month
-17.17%
-17.17%
6 Month
+4.10%
+4.10%
1 Year
+12.10%
+12.10%
Top News
More News
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA® (ozanimod) for the Treatment of Adult Patients with Relapsing Remitting Multiple Sclerosis with Active Disease
BMS Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA for the Treatment.... Read More
from Business Wire News Releases
My Top Healthcare Stocks to Buy in the Market Crash
Profitable. Great revenue and earnings growth. Strong market potential. These stocks check off all the boxes. Read More
category ISRG , VRTX , BMY , and 1 more.
from Motley Fool
More News
Read More
The Sell-Off Reversal?
category Financial , Consumer Goods , Basic Materials / Commodities , and 8 more.
from Blogs - TalkMarkets
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
category Medical Products , General , LLY , and 10 more.
from MarketWatch
New England Journal of Medicine Publishes Results from Pivotal Phase 3 BELIEVE Trial of Reblozyl (luspatercept-aamt) in Adult Patients With Beta Thalassemia
from Business Wire News Releases
65 Firms Going Ex-Dividend Next Week, Including State Street, Cardinal Health And Ventas
category Stocks / Equities
from Blogs - TalkMarkets
My Top 3 Drug Stocks to Buy in the Market Crash
category SNY , BMY , Market News , and 1 more.
from Motley Fool
Drugmaker Vertex to delay new clinical studies due to coronavirus
category companyNews
from Reuters: Company News
Why Bristol-Myers Squibb's Stock is Trading Higher Today
category News , Trading Ideas , FDA , and 5 more.
from Benzinga
Is Bristol Myers Squibb Stock a Buy?
category BMY , Market News , PFE
from Motley Fool
Better Buy: Geron vs. Acceleron
category GERN , XLRN , INCY , and 3 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.